awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38557067-35A51A50-9150-493F-903C-DEE2BFD27737
Q38557067-35A51A50-9150-493F-903C-DEE2BFD27737
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38557067-35A51A50-9150-493F-903C-DEE2BFD27737
Ibrutinib: from bench side to clinical implications.
P2860
Q38557067-35A51A50-9150-493F-903C-DEE2BFD27737
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38557067-35A51A50-9150-493F-903C-DEE2BFD27737
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b4d2314c5e738f6a98a0ac1bcc6ebfdb154c892
P2860
The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia.